Trial Profile
A Double-blind, Placebo-controlled, Fixed-dose Study of Vilazodone in Patients With Major Depressive Disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Apr 2018
Price :
$35
*
At a glance
- Drugs Vilazodone (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Forest Laboratories
- 30 Mar 2018 Results (n=2218) of post-hoc analysis of four randomized trials assessing efficacy in subgroups of patients with major depressive disorder, were published in the International Clinical Psychopharmacology.
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.